EWTX
Edgewise Therapeutics Inc

549
Mkt Cap
$2.7B
Volume
479,577.00
52W High
$35.50
52W Low
$10.60
PE Ratio
-16.51
EWTX Fundamentals
Price
$26.04
Prev Close
$25.52
Open
$25.62
50D MA
$17.72
Beta
1.35
Avg. Volume
833,324.35
EPS (Annual)
-$1.45
P/B
4.93
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Wall Street Zen Upgrades Edgewise Therapeutics (NASDAQ:EWTX) to "Hold"
Wall Street Zen raised Edgewise Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...
MarketBeat·7d ago
News Placeholder
More News
News Placeholder
Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors
Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of Directors Edgewise Therapeutics Appoints Commercial Biotech Executive Christopher Martin to its Board of...
PR Newswire·9d ago
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Given New $34.00 Price Target at JPMorgan Chase & Co.
JPMorgan Chase & Co. boosted their target price on shares of Edgewise Therapeutics from $33.00 to $34.00 and gave the stock an "overweight" rating in a research note on Friday...
MarketBeat·13d ago
News Placeholder
Jonathan Fox Purchases 10,700 Shares of Edgewise Therapeutics (NASDAQ:EWTX) Stock
Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) Director Jonathan Fox acquired 10,700 shares of Edgewise Therapeutics stock in a transaction on Tuesday, November 11th. The stock was...
MarketBeat·13d ago
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Insider Sells $2,112,000.00 in Stock
Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) insider Alan Russell sold 100,000 shares of the company's stock in a transaction dated Wednesday, November 12th. The shares were sold at an...
MarketBeat·13d ago
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Director Jonathan Fox Buys 10,700 Shares
Edgewise Therapeutics, Inc. (NASDAQ:EWTX - Get Free Report) Director Jonathan Fox bought 10,700 shares of Edgewise Therapeutics stock in a transaction dated Tuesday, November 11th. The stock was...
MarketBeat·15d ago
News Placeholder
Edgewise Therapeutics (NASDAQ:EWTX) Trading 7.9% Higher - Here's Why
Edgewise Therapeutics (NASDAQ:EWTX) Stock Price Up 7.9% - What's Next...
MarketBeat·16d ago
News Placeholder
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules
Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules Edgewise Therapeutics Reports Inducement Grants as permitted by the Nasdaq Listing Rules PR Newswire BOULDER...
PR Newswire·17d ago
News Placeholder
Edgewise Therapeutics Names Michael Nofi New CFO As Michael Carruthers Retires
(RTTNews) - Edgewise Therapeutics, Inc., (EWTX), a biopharmaceutical company, Monday announced that it has appointed Michael Nofi as its new chief financial officer, effective November 10...
Nasdaq News: Markets·19d ago
News Placeholder
Edgewise Therapeutics Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers
Edgewise Therapeutics Announces Appointment of Michael Nofi as Chief Financial Officer, and the Retirement of Current CFO, R. Michael Carruthers Edgewise Therapeutics Announces Appointment of Michael...
PR Newswire·19d ago

Latest EWTX News

View

Advertisement|Remove ads.

Advertisement|Remove ads.